310 related articles for article (PubMed ID: 27242795)
1. NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation.
Vacca P; Montaldo E; Croxatto D; Moretta F; Bertaina A; Vitale C; Locatelli F; Mingari MC; Moretta L
Front Immunol; 2016; 7():188. PubMed ID: 27242795
[TBL] [Abstract][Full Text] [Related]
2. NK cells and ILCs in tumor immunotherapy.
Sivori S; Pende D; Quatrini L; Pietra G; Della Chiesa M; Vacca P; Tumino N; Moretta F; Mingari MC; Locatelli F; Moretta L
Mol Aspects Med; 2021 Aug; 80():100870. PubMed ID: 32800530
[TBL] [Abstract][Full Text] [Related]
3. Development of human natural killer cells and other innate lymphoid cells.
Montaldo E; Vacca P; Moretta L; Mingari MC
Semin Immunol; 2014 Apr; 26(2):107-13. PubMed ID: 24559836
[TBL] [Abstract][Full Text] [Related]
4. Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.
Zaghi E; Calvi M; Di Vito C; Mavilio D
Front Immunol; 2019; 10():2794. PubMed ID: 31849972
[TBL] [Abstract][Full Text] [Related]
5. The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.
Moretta F; Petronelli F; Lucarelli B; Pitisci A; Bertaina A; Locatelli F; Mingari MC; Moretta L; Montaldo E
Eur J Immunol; 2016 May; 46(5):1271-8. PubMed ID: 26840535
[TBL] [Abstract][Full Text] [Related]
6. IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors.
Ambrosini P; Loiacono F; Conte R; Moretta L; Vitale C; Mingari MC
Eur J Immunol; 2015 Jul; 45(7):2061-71. PubMed ID: 25847448
[TBL] [Abstract][Full Text] [Related]
7. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Vacca P; Munari E; Tumino N; Moretta F; Pietra G; Vitale M; Del Zotto G; Mariotti FR; Mingari MC; Moretta L
Immunol Lett; 2018 Sep; 201():14-19. PubMed ID: 30439479
[TBL] [Abstract][Full Text] [Related]
8. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
[TBL] [Abstract][Full Text] [Related]
9. Innate lymphoid cell recovery and occurrence of GvHD after hematopoietic stem cell transplantation.
Piperoglou C; Larid G; Vallentin B; Balligand L; Crinier A; Banzet N; Farnarier C; Gomez-Massa E; Adalia AC; ; Michel G; Galambrun C; Barlogis V; Vivier E; Vély F
J Leukoc Biol; 2022 Jan; 111(1):161-172. PubMed ID: 33847423
[TBL] [Abstract][Full Text] [Related]
10. Innate Lymphoid Cells in Protection, Pathology, and Adaptive Immunity During Apicomplexan Infection.
Ivanova DL; Denton SL; Fettel KD; Sondgeroth KS; Munoz Gutierrez J; Bangoura B; Dunay IR; Gigley JP
Front Immunol; 2019; 10():196. PubMed ID: 30873151
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids inhibit human hematopoietic stem cell differentiation toward a common ILC precursor.
Quatrini L; Tumino N; Besi F; Ciancaglini C; Galaverna F; Grasso AG; Merli P; Locatelli F; Vacca P; Moretta L
J Allergy Clin Immunol; 2022 May; 149(5):1772-1785. PubMed ID: 34688777
[TBL] [Abstract][Full Text] [Related]
12. Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.
Mariotti FR; Quatrini L; Munari E; Vacca P; Moretta L
Front Immunol; 2019; 10():910. PubMed ID: 31105707
[TBL] [Abstract][Full Text] [Related]
13. Human ectoenzyme-expressing ILC3: immunosuppressive innate cells that are depleted in graft-versus-host disease.
Hazenberg MD; Haverkate NJE; van Lier YF; Spits H; Krabbendam L; Bemelman WA; Buskens CJ; Blom B; Shikhagaie MM
Blood Adv; 2019 Nov; 3(22):3650-3660. PubMed ID: 31751473
[TBL] [Abstract][Full Text] [Related]
14. Human innate lymphoid cells.
Montaldo E; Vacca P; Vitale C; Moretta F; Locatelli F; Mingari MC; Moretta L
Immunol Lett; 2016 Nov; 179():2-8. PubMed ID: 26844414
[TBL] [Abstract][Full Text] [Related]
15. Group 3 innate lymphoid cells in tissue damage and graft-versus-host disease pathogenesis.
Karrich JJ; Cupedo T
Curr Opin Hematol; 2016 Jul; 23(4):410-5. PubMed ID: 27135976
[TBL] [Abstract][Full Text] [Related]
16. Innate lymphoid cells in graft-versus-host disease.
Konya V; Mjösberg J
Am J Transplant; 2015 Nov; 15(11):2795-801. PubMed ID: 26228632
[TBL] [Abstract][Full Text] [Related]
17. NK Cell Reconstitution in Paediatric Leukemic Patients after T-Cell-Depleted HLA-Haploidentical Haematopoietic Stem Cell Transplantation Followed by the Reinfusion of iCasp9-Modified Donor T Cells.
Stabile H; Nisti P; Fionda C; Pagliara D; Gaspari S; Locatelli F; Santoni A; Gismondi A
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31703320
[TBL] [Abstract][Full Text] [Related]
18. Specific Patterns of Blood ILCs in Metastatic Melanoma Patients and Their Modulations in Response to Immunotherapy.
Rethacker L; Roelens M; Bejar C; Maubec E; Moins-Teisserenc H; Caignard A
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33810032
[TBL] [Abstract][Full Text] [Related]
19. Understanding human NK cell differentiation: clues for improving the haploidentical hematopoietic stem cell transplantation.
Montaldo E; Vacca P; Moretta L; Mingari MC
Immunol Lett; 2013; 155(1-2):2-5. PubMed ID: 24076313
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and Functional Characterization of NK Cells in αβT-Cell and B-Cell Depleted Haplo-HSCT to Cure Pediatric Patients with Acute Leukemia.
Meazza R; Falco M; Loiacono F; Canevali P; Della Chiesa M; Bertaina A; Pagliara D; Merli P; Indio V; Galaverna F; Algeri M; Moretta F; Colomar-Carando N; Muccio L; Sivori S; Pession A; Mingari MC; Moretta L; Moretta A; Locatelli F; Pende D
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
